Type 1 diabetes is associated with such complications as blindness, kidney failure, and nerve damage. Replacing C-peptide, a hormone normally co-secreted with insulin, has been shown to reduce diabetes-related complications. Interestingly, after nearly 30 years of positive research results, C-peptide is still not being co-administered with insulin to diabetic patients. The following review discusses the potential of C-peptide as an auxilliary replacement therapy and why it's not currently being used as a therapeutic.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796410 | PMC |
| http://dx.doi.org/10.1039/c7mb00199a | DOI Listing |
Publication Analysis
Top Keywords
replacement therapy
8
type diabetes
8
c-peptide
4
c-peptide replacement
4
therapy type
4
diabetes trough
4
trough disillusionment?
4
disillusionment? type
4
diabetes associated
4
associated complications
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!